195 related articles for article (PubMed ID: 23070562)
1. Solid dispersion of ursolic acid in Gelucire 50/13: a strategy to enhance drug release and trypanocidal activity.
de Oliveira Eloy J; Saraiva J; de Albuquerque S; Marchetti JM
AAPS PharmSciTech; 2012 Dec; 13(4):1436-45. PubMed ID: 23070562
[TBL] [Abstract][Full Text] [Related]
2. Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13.
Potluri RH; Bandari S; Jukanti R; Veerareddy PR
Arch Pharm Res; 2011 Jan; 34(1):51-7. PubMed ID: 21468915
[TBL] [Abstract][Full Text] [Related]
3. Preparation of ursolic acid-phospholipid complex by solvent-assisted grinding method to improve dissolution and oral bioavailability.
Wang W; Zhang W; Jiang Y; Wang X; Zhang X; Liu H; Zhang T
Pharm Dev Technol; 2020 Jan; 25(1):68-75. PubMed ID: 31544585
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
5. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
Dhumal RS; Biradar SV; Aher S; Paradkar AR
J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
[TBL] [Abstract][Full Text] [Related]
6. Triple Strategies to Improve Oral Bioavailability by Fabricating Coamorphous Forms of Ursolic Acid with Piperine: Enhancing Water-Solubility, Permeability, and Inhibiting Cytochrome P450 Isozymes.
Yu D; Kan Z; Shan F; Zang J; Zhou J
Mol Pharm; 2020 Dec; 17(12):4443-4462. PubMed ID: 32926628
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique.
Chauhan B; Shimpi S; Paradkar A
Eur J Pharm Sci; 2005 Oct; 26(2):219-30. PubMed ID: 16087324
[TBL] [Abstract][Full Text] [Related]
8. Development and Evaluation of a Nanoemulsion Containing Ursolic Acid: a Promising Trypanocidal Agent : Nanoemulsion with Ursolic Acid Against T. cruzi.
Vargas de Oliveira EC; Carneiro ZA; de Albuquerque S; Marchetti JM
AAPS PharmSciTech; 2017 Oct; 18(7):2551-2560. PubMed ID: 28224391
[TBL] [Abstract][Full Text] [Related]
9. Preparation and Characterization of Poloxamer 407 Solid Dispersions as an Alternative Strategy to Improve Benznidazole Bioperformance.
Simonazzi A; Davies C; Cid AG; Gonzo E; Parada L; Bermúdez JM
J Pharm Sci; 2018 Nov; 107(11):2829-2836. PubMed ID: 30005984
[TBL] [Abstract][Full Text] [Related]
10. Improvement in oral bioavailability and dissolution of tanshinone IIA by preparation of solid dispersions with porous silica.
Yan HM; Sun E; Cui L; Jia XB; Jin X
J Pharm Pharmacol; 2015 Sep; 67(9):1207-14. PubMed ID: 25944009
[TBL] [Abstract][Full Text] [Related]
11. Dual Activity of Hydroxypropyl-β-Cyclodextrin and Water-Soluble Carriers on the Solubility of Carvedilol.
Zoghbi A; Geng T; Wang B
AAPS PharmSciTech; 2017 Nov; 18(8):2927-2935. PubMed ID: 28432614
[TBL] [Abstract][Full Text] [Related]
12. Ursolic Acid Nanocrystals for Dissolution Rate and Bioavailability Enhancement: Influence of Different Particle Size.
Pi J; Liu Z; Wang H; Gu X; Wang S; Zhang B; Luan H; Zhu Z
Curr Drug Deliv; 2016; 13(8):1358-1366. PubMed ID: 26953239
[TBL] [Abstract][Full Text] [Related]
13. An Approach to Enhance Dissolution Rate of Tamoxifen Citrate.
SreeHarsha N; Hiremath JG; Chilukuri S; Aitha RK; Al-Dhubiab BE; Venugopala KN; Alzahrani AM; Meravanige G
Biomed Res Int; 2019; 2019():2161348. PubMed ID: 30800663
[TBL] [Abstract][Full Text] [Related]
14. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
[TBL] [Abstract][Full Text] [Related]
15. Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies.
Eedara BB; Veerareddy PR; Jukanti R; Bandari S
Drug Dev Ind Pharm; 2014 Aug; 40(8):1030-43. PubMed ID: 23738504
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of spironolactone-loaded gelucire microparticles using spray-drying technique.
Yassin AE; Alanazi FK; El-Badry M; Alsarra IA; Barakat NS; Alanazi FK
Drug Dev Ind Pharm; 2009 Mar; 35(3):297-304. PubMed ID: 18821154
[TBL] [Abstract][Full Text] [Related]
17. Acyclovir-Polyethylene Glycol 6000 Binary Dispersions: Mechanistic Insights.
Venkateskumar K; Parasuraman S; Gunasunderi R; Sureshkumar K; Nayak MM; Shah SAA; Khoo K; Kai HW
AAPS PharmSciTech; 2017 Aug; 18(6):2085-2094. PubMed ID: 28004342
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000.
Aggarwal AK; Singh S
Drug Dev Ind Pharm; 2011 Oct; 37(10):1181-91. PubMed ID: 21449824
[TBL] [Abstract][Full Text] [Related]
19. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
Ghanavati R; Taheri A; Homayouni A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
[TBL] [Abstract][Full Text] [Related]
20. Enhanced bioavailability and hepatoprotectivity of optimized ursolic acid-phospholipid complex.
Biswas S; Mukherjee PK; Harwansh RK; Bannerjee S; Bhattacharjee P
Drug Dev Ind Pharm; 2019 Jun; 45(6):946-958. PubMed ID: 30767678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
